142 related articles for article (PubMed ID: 37069408)
21. Impact of adjuvant chemotherapy in patients with curatively resected stage IV colorectal cancer.
Kobayashi H; Kotake K; Sugihara K;
Medicine (Baltimore); 2015 May; 94(17):e696. PubMed ID: 25929899
[TBL] [Abstract][Full Text] [Related]
22. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA
Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal exfoliated cancer cells in patients with colorectal cancer.
Hase K; Ueno H; Kuranaga N; Utsunomiya K; Kanabe S; Mochizuki H
Dis Colon Rectum; 1998 Sep; 41(9):1134-40. PubMed ID: 9749497
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database.
Ozawa H; Kotake K; Kobayashi H; Kobayashi H; Sugihara K
Surg Today; 2014 Sep; 44(9):1643-50. PubMed ID: 24077999
[TBL] [Abstract][Full Text] [Related]
25. Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis.
Kobayashi H; Kotake K; Funahashi K; Hase K; Hirata K; Iiai T; Kameoka S; Kanemitsu Y; Maeda K; Murata A; Ohue M; Shirouzu K; Takahashi K; Watanabe T; Yano H; Yatsuoka T; Hashiguchi Y; Sugihara K;
J Gastroenterol; 2014 Apr; 49(4):646-54. PubMed ID: 23793379
[TBL] [Abstract][Full Text] [Related]
26. Role of Repeat Resection in Patients With Metastatic Colorectal Cancer: A Multicenter Retrospective Study.
Matsumoto T; Hasegawa S; Hida K; Kawada K; Sakai Y; Sugihara K
Dis Colon Rectum; 2019 May; 62(5):561-567. PubMed ID: 30614848
[TBL] [Abstract][Full Text] [Related]
27. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
[TBL] [Abstract][Full Text] [Related]
28. Non-curative surgery for patients with gastric cancer with local peritoneal metastasis: A retrospective cohort study.
Dong Y; Ma S; Yang S; Luo F; Wang Z; Guo F
Medicine (Baltimore); 2016 Dec; 95(49):e5607. PubMed ID: 27930586
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
[TBL] [Abstract][Full Text] [Related]
30. Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?
Gelli M; Huguenin JFL; de Baere T; Benhaim L; Mariani A; Boige V; Malka D; Sourouille I; Ducreux M; Elias D; Goéré D
Eur J Cancer; 2018 Sep; 100():94-103. PubMed ID: 30014885
[TBL] [Abstract][Full Text] [Related]
31. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
Quénet F; Elias D; Roca L; Goéré D; Ghouti L; Pocard M; Facy O; Arvieux C; Lorimier G; Pezet D; Marchal F; Loi V; Meeus P; Juzyna B; de Forges H; Paineau J; Glehen O;
Lancet Oncol; 2021 Feb; 22(2):256-266. PubMed ID: 33476595
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
Jeon Y; Park EJ; Lim JH; Baik SH
World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188
[TBL] [Abstract][Full Text] [Related]
33. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
Nakayama I; Suenaga M; Wakatsuki T; Ichimura T; Ozaka M; Takahari D; Shinozaki E; Chin K; Ueno M; Mizunuma N; Yamaguchi T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):133-9. PubMed ID: 25994854
[TBL] [Abstract][Full Text] [Related]
34. Solitary colorectal liver metastasis after curative intent surgery: prognostic factors affecting outcomes and survival.
Shin H; Kim CW; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
ANZ J Surg; 2019 Jan; 89(1-2):61-67. PubMed ID: 30484933
[TBL] [Abstract][Full Text] [Related]
35. [Estimation of peritoneal dissemination in patients with unresectable advanced or recurrent colorectal cancer who underwent curative resection after combination chemotherapy].
Mizota S; Ikeda S; Yamauchi M; Imaoka Y; Mashima H; Okimoto S; Takakura Y; Noma M; Ohara M; Oishi K; Kohashi T; Fudaba Y; Ishimoto T; Matsugu Y; Nakahara H; Urushihara T; Shinozaki K; Itamoto T
Gan To Kagaku Ryoho; 2014 May; 41(5):595-600. PubMed ID: 24917004
[TBL] [Abstract][Full Text] [Related]
36. Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC.
Sluiter NR; Rovers KP; Salhi Y; Vlek SL; Coupé VMH; Verheul HMW; Kazemier G; de Hingh IHJT; Tuynman JB
Ann Surg Oncol; 2018 Aug; 25(8):2347-2356. PubMed ID: 29855834
[TBL] [Abstract][Full Text] [Related]
37. [Short-term outcomes and prognosis of palliative surgery for malignant bowel obstruction caused by peritoneal metastasis of colorectal cancer].
Chen PJ; Wang L; Chen N; Lu XY; Wang HS; He X; Wang Z; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1051-1057. PubMed ID: 31770836
[No Abstract] [Full Text] [Related]
38. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study.
Maggiori L; Goéré D; Viana B; Tzanis D; Dumont F; Honoré C; Eveno C; Elias D
Ann Surg; 2013 Jul; 258(1):116-21. PubMed ID: 23207243
[TBL] [Abstract][Full Text] [Related]
39. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Bijelic L; Yan TD; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
[TBL] [Abstract][Full Text] [Related]
40. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
Lorimier G; Linot B; Paillocher N; Dupoiron D; Verrièle V; Wernert R; Hamy A; Capitain O
Eur J Surg Oncol; 2017 Jan; 43(1):150-158. PubMed ID: 27839895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
